Olumiant is a prescription medicine used to treat adults with moderate-to-severe active rheumatoid arthritis (RA). Olumiant 4mg is a Janus kinase (JAK) inhibitor, which means that it blocks the activity of certain proteins that are involved in the body's inflammatory response.
The recent approval of Olumiant (baricitinib) to treat moderate-to-severe active rheumatoid arthritis (RA) is a major breakthrough in the treatment of this debilitating condition. RA is a chronic autoimmune disorder that causes inflammation and pain in the joints, leading to long-term disability and a reduced quality of life.
Olumiant works by blocking the activity of certain proteins called Janus kinase (JAK) inhibitors. These proteins are involved in the body's inflammatory response, and by inhibiting their activity, Olumiant can reduce inflammation and pain in affected joints. It has been found to be more effective than other RA treatments, such as disease-modifying anti-rheumatic drugs (DMARDs) and biologics, in reducing signs and symptoms of RA.
In clinical trials, Olumiant was found to be more effective than other treatments in reducing inflammation and providing relief from RA symptoms. The medication also improved quality of life for people living with RA. Additionally, it was shown to reduce the number of flare-ups and the amount of time it took to get back to normal daily activities. In addition to reducing inflammation, Olumiant also helps to improve joint damage caused by RA. It can prevent further joint damage, as well as help to repair existing damage.
You can buy Olumiant at softcarepharmacy.com.